These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24890535)

  • 41. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
    Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
    Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
    Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
    BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
    Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
    J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.
    Lala RI; Lungeanu D; Darabantiu D; Pilat L; Puschita M
    Herz; 2018 Mar; 43(2):146-155. PubMed ID: 28235980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.
    Lok DJ; Van Der Meer P; de la Porte PW; Lipsic E; Van Wijngaarden J; Hillege HL; van Veldhuisen DJ
    Clin Res Cardiol; 2010 May; 99(5):323-8. PubMed ID: 20130888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
    Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
    Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis.
    Chen H; Chen C; Fang J; Wang R; Nie W
    Heart Fail Rev; 2020 Mar; 25(2):331-341. PubMed ID: 31641977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure.
    Kamiya K; Sato Y; Takahashi T; Tsuchihashi-Makaya M; Kotooka N; Ikegame T; Takura T; Yamamoto T; Nagayama M; Goto Y; Makita S; Isobe M
    Circ Heart Fail; 2020 Oct; 13(10):e006798. PubMed ID: 32986957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the Diastolic Stress Test With a Combined Resting Echocardiography and Biomarker Approach to Patients With Exertional Dyspnea: Diagnostic and Prognostic Implications.
    Kosmala W; Przewlocka-Kosmala M; Rojek A; Marwick TH
    JACC Cardiovasc Imaging; 2019 May; 12(5):771-780. PubMed ID: 29454783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure.
    French B; Wang L; Ky B; Brandimarto J; Basuray A; Fang JC; Sweitzer NK; Cappola TP
    J Card Fail; 2016 Apr; 22(4):256-62. PubMed ID: 26571149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Samsky MD; Dunning A; DeVore AD; Schulte PJ; Starling RC; Tang WH; Armstrong PW; Ezekowitz JA; Butler J; McMurray JJ; Teerlink JR; Voors AA; Metra M; Mentz RJ; O'Connor CM; Patel CB; Hernandez AF
    Eur J Heart Fail; 2016 Apr; 18(4):424-32. PubMed ID: 26707029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.